DP

David P. Luci

President, Chief Executive Officer, Director, Co-Founder

Acurx Pharmaceuticals

Acurx Pharmaceuticals Pipeline

DrugIndicationPhase
Ibezapolstat (ACX-362E)Clostridioides difficile Infection (CDI)Phase 2b
ACX-375CGram-Positive Infections (e.g., MRSA, VRE)Preclinical